Fast, easy summary view of NICE guidance on 'tuberculosis'
This clinical guideline updates and replaces NICE clinical guideline 33 (published March 2006). New recommendations on using interferon-gamma tests for the diagnosis of latent tuberculosis have been added.
The guideline offers evidence-based advice on the diagnosis and treatment of active and latent tuberculosis in adults and children, and on preventing the spread of tuberculosis, for example by offering tests to people at high risk, and by vaccination. The guideline does not explain tuberculosis or its treatments in detail.
This guideline is currently being updated. Further information can be found on the Tuberculosis (update) page.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: tuberculosis
This page was last updated: 21 March 2014
- Web format
- NICE Guideline (PDF)
- Full Guideline
- CG117 Twbercwlosis: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
- Audit support
- Baseline assessment tool
- Costing report
- Costing statement
- Costing template
- Slide set
- Tuberculosis online educational tool
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.